The Efficacy of Jalinous tablet compared with Placebo on adult functional constipatio

Phase 3

• Conditions: Functional Constipation.; Constipation, unspecified; K59.00

• Registration Number: IRCT20190312043025N1
• Lead Sponsor: Shiraz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 126

Inclusion Criteria

18 to 50 years old
Ability to understand, speak and answer the questions
Qualified for ROME IV functional constipation
Confirmed functional constipation diagnosis by gastrointestinal specialist
Non-pregnancy and lactation
Complete the consent form

Exclusion Criteria

New disease that may lead to hospitalization or new medications
Use other laxatives when studying more than 2 times a week
Drug Addiction
Alarm signs (rectal bleeding, fever, loss of appetite, weight loss, ...)
Incidence of severe side effect of the study drug
The patient's unwillingness to continue participating in the study for any reason
No regular drug use (more than 7 days)
Have a history of allergy to aloe Vera, rose, Indian Jalap and mastic
Recent use of antacid, anticholinergic, anti Parkinson, anti psychotic and tricyclic antidepressants, anticonvulsants, antidepressants, diuretics and calcium blockers, iron products, opioids, calcium, prophylaxis Contains progesterone
Previous history of any abdominal and gastrointestinal surgery

Study & Design

• Study Type: interventional
• Study Design: Not specified